Lv1
62 积分 2026-03-15 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
2个月前
已完结
Synthesis of Secondary N-Methylamines via Reductive Amination of Aldehydes with N-Boc-N-Methylamine Using Me2SiHCl
2个月前
已完结
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5-Azaindole Core
3个月前
已完结
First Selective Covalent FGFR3 Inhibitors: Conquering Toxicity and Resistance
3个月前
已完结
Systematic cysteine scanning identifies a druggable pocket in oncogenic KRAS
3个月前
已关闭
Optimization of Covalent Warhead Trajectory for KRASG12C Active-State Inhibition
3个月前
已完结
皖公网安备34019202002308
